Therapeutic Dose Monitoring (TDM) of Tamoxifen
Conditions: Breast Cancer; Breast Carcinoma; Breast Tumors; Cancer of Breast; Malignant Neoplasm of Breast Intervention: Drug: Tamoxifen 20 mg Sponsor: Karolinska University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Hospitals | Research | Tamoxifen